{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T22:44:44Z","timestamp":1783723484891,"version":"3.55.0"},"reference-count":33,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo Clemente Estable","award":["FCE_3_ 2022_1_ 172684"],"award-info":[{"award-number":["FCE_3_ 2022_1_ 172684"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mem. Inst. Oswaldo Cruz"],"abstract":"<jats:p> BACKGROUND  The neglected illness Chagas disease is treated with limited efficacy and adverse effects by old drugs. Due to the low interest of pharmaceutical industry in targeting economically depressed-patients, repurposing is a tool that should be applied because it can introduce new anti-Chagas entities into the clinic at reduced costs.  OBJECTIVES  To investigate the repurposing\/combination of medicines strategies as anti-Chagas treatment.  METHODS  Epimastigotes, trypomastigotes and amastigotes of Trypanosoma cruzi were in vitro exposed to 28 Uruguayan-approved medicines not previously tested, 28 FDA-approved medicines previously evaluated, and three reference agents. Parasite inhibition was assessed and for the best drugs, in pairs-isobolographic studies, looking for synergism\/additivity\/antagonism, were done. Macrophages were used to study selectivity. For some relevant agents, we analysed whether medicines mammals\u00b4 action mechanisms are operative in epimastigotes-T. cruzi.  FINDINGS  From the anti-epimastigotes monotherapy-screening, we found that 18% of them showed better\/comparable activities than references. Additionally, for the binary-combinations 8% were additive, 4% were synergic and the rest showed antagonism. Favourably, in macrophages-cytotoxicity four of the binary-combinations were antagonists. Naftazone and pinaverium bromide, not previously tested against T. cruzi, maintained their activity against trypomastigotes and amastigotes. The identified action mechanisms open the door to new strategies designing anti-T. cruzi drugs.  MAIN CONCLUSIONS Using approved-medicines is a good strategy for new anti-Chagas treatments.<\/jats:p>","DOI":"10.1590\/0074-02760240183","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:30:14Z","timestamp":1740051014000},"source":"Crossref","is-referenced-by-count":4,"title":["Looking for approved-medicines to be repositioned as anti-Trypanosoma cruzi agents. Identification of new chemotypes with good individual- or in combination-biological behaviours"],"prefix":"10.1590","volume":"120","author":[{"given":"Claudia","family":"Veira","sequence":"first","affiliation":[{"name":"Universidad de la Rep\u00fablica,  Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Ben\u00edtez","sequence":"additional","affiliation":[{"name":"Institut Pasteur de Montevideo,  Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leticia","family":"P\u00e9rez-D\u00edaz","sequence":"additional","affiliation":[{"name":"Universidad de la Rep\u00fablica,  Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guzm\u00e1n","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Universidad de la Rep\u00fablica,  Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1256-3786","authenticated-orcid":false,"given":"Hugo","family":"Cerecetto","sequence":"additional","affiliation":[{"name":"Universidad de la Rep\u00fablica,  Uruguay; Universidad de la Rep\u00fablica,  Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-687X","authenticated-orcid":false,"given":"Elena","family":"Aguilera","sequence":"additional","affiliation":[{"name":"Universidad de la Rep\u00fablica,  Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref1","year":"2022"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1645\/15-748","article-title":"The biology of the Triatomine bugs native to South Central Texas and assessment of the risk they pose for autochthonous Chagas disease exposure","volume":"101","author":"Wozniak EJ","year":"2015","journal-title":"J Parasitol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"102284","DOI":"10.1016\/j.tmaid.2022.102284","article-title":"Estimating Chagas disease prevalence and number of underdiagnosed, and undertreated individuals in Spain","volume":"47","author":"Navarro M","year":"2022","journal-title":"Travel Med Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000484","article-title":"New, improved treatments for Chagas disease from the R&D pipeline to the patients","volume":"3","author":"Ribeiro I","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3390\/ph3040810","article-title":"Synthetic medicinal chemistry in Chagas' disease compounds at the final stage of \"Hit-to-Lead\" phase","volume":"3","author":"Cerecetto H","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1017\/S0031182022001081","article-title":"Monotherapy and combination chemotherapy for Chagas disease treatment a systematic review of clinical efficacy and safety based on randomized controlled trials","volume":"149","author":"Nogueira SS","year":"2022","journal-title":"Parasitology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1128\/AAC.32.8.1237","article-title":"Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi","volume":"32","author":"Urbina JA","year":"1988","journal-title":"Antimicrob Agents Chemother"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0166-6851(98)00053-X","article-title":"The effects of protein farnesyltransferase inhibitors on trypanosomatids inhibition of protein farnesylation and cell growth","volume":"94","author":"Yokoyama K","year":"1998","journal-title":"Mol Biochem Parasitol"},{"key":"ref9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002977","article-title":"Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi","volume":"8","author":"Planer JD","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.2174\/0929867325666180410101728","article-title":"Polypharmacology in the treatment of Chagas disease","volume":"26","author":"Aguilera E","year":"2019","journal-title":"Curr Med Chem"},{"key":"ref11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007481","article-title":"Crystal violet structural analogues identified by in silico drug repositioning present anti-Trypanosoma cruzi activity through inhibition of proline transporter TcAAAP069","volume":"14","author":"Say\u00e9 M","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijcard.2019.07.047","article-title":"Combination therapy with benznidazole and doxycycline shows no additive effect to monotherapy with benznidazole in mice infected with the VL-10 strain of the Trypanosoma cruzi","volume":"299","author":"Carneiro ACA","year":"2020","journal-title":"Int J Cardiol"},{"issue":"3","key":"ref13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/0074-02760170267","article-title":"Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment","volume":"113","author":"Aguilera E","year":"2018","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"47225","DOI":"10.1021\/acsomega.2c06455","article-title":"Synthesis and antitrypanosomal and mechanistic studies of a series of 2-arylquinazolin-4-hydrazines a hydrazine moiety as a selective, safe, and specific pharmacophore to design antirypanosomal agents targeting NO release","volume":"7","author":"Romero AH","year":"2022","journal-title":"ACS Omega"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1039\/D3MD00243H","article-title":"Optimization of the 2-arylquinazoline-4(3H)one scaffold for a selective and potent antitrypanosomal agent modulation of the mechanism of action through chemical functionalization","volume":"14","author":"Romero AH","year":"2023","journal-title":"RSC Med Chem"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s10534-018-0140-4","article-title":"Effect of a new anti-T cruzi metallic compound based on palladium","volume":"31","author":"Mosquillo MF","year":"2018","journal-title":"Biometals"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1128\/AAC.22.5.743","article-title":"Synergism between aminoglycosides and cephalosporins with antipseudomonal activity interaction index and killing curve method","volume":"22","author":"Hallander HO","year":"1982","journal-title":"Antimicrob Agents Chemother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1476-5381.1992.tb14279.x","article-title":"Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle","volume":"105","author":"Feron O","year":"1992","journal-title":"Br J Pharmacol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0306-3623(90)90439-S","article-title":"Action of pinaverium bromide, a calcium-antagonist, on gastrointestinal motility disorders","volume":"21","author":"Christen MO","year":"1990","journal-title":"Gen Pharmac"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8044","DOI":"10.1016\/j.bmc.2010.09.015","article-title":"Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines in vitro evaluation and structure-activity relationship study","volume":"18","author":"Reim\u00e3o JQ","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"ref21","first-page":"43","article-title":"Atividade terap\u00e9utica do 5-nitro-furalde\u00eddo-semicarbazona (nitrofurazona) em esquemas de dura\u00e7\u00e3o prolongada na infec\u00e7\u00e3o experimental do camundongo pelo Trypanosoma cruzi","volume":"3","author":"Brener Z","year":"1961","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.3390\/molecules26113372","article-title":"In vitro and in vivo trypanocidal efficacy of synthesized nitrofurantoin analogs","volume":"26","author":"Munsimbwe L","year":"2021","journal-title":"Molecules"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1021\/acsinfecdis.7b00212","article-title":"Optimization of physicochemical properties for 4-anilinoquinoline inhibitors of Plasmodium falciparum Proliferation","volume":"4","author":"Mehta N","year":"2018","journal-title":"ACS Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/jac\/45.6.819","article-title":"A combination of benznidazole and ketoconazole enhances efficacy of chemotherapy of experimental Chagas' disease","volume":"45","author":"Ara\u00fajo MSS","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1128\/AAC.37.6.1353","article-title":"Experimental chemotherapy with combinations of ergosterol biosynthesis inhibitors in murine models of Chagas' disease","volume":"37","author":"Maldonado RA","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1124\/jpet.123.001669","article-title":"Mechanism of analgesia by gabapentinoid drugs involvement of modulation of synaptogenesis and trafficking of glutamate-gated ion channels","volume":"388","author":"Varadi G","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/jch.14709","article-title":"Amlodipine in the current management of hypertension","volume":"25","author":"Wang JG","year":"2023","journal-title":"J Clin Hypertens"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1476-5381.1992.tb14279.x","article-title":"Interaction of pinaverium (a quaternary ammonium compound) with 1,4-dihydropyridine binding sites in rat ileum smooth muscle","volume":"105","author":"Feron O","year":"1992","journal-title":"Br J Pharmacol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0304-3940(99)00552-2","article-title":"Naftazone reduces glutamate cerebro spinal fluid levels in rats and glutamate release from mouse cerebellum synaptosomes","volume":"271","author":"Mattei C","year":"1999","journal-title":"Neurosci Lett"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1043-6618(05)80015-5","article-title":"Lipid peroxidation and lysosomal integrity in different inflammatory models in rats the effects of indomethacin and naftazone","volume":"32","author":"Agha AM","year":"1995","journal-title":"Pharmacol Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.3892\/mmr.2016.4819","article-title":"Effect of glutamate on lysosomal membrane permeabilization in primary cultured cortical neurons","volume":"13","author":"Yan M","year":"2016","journal-title":"Mol Med Rep"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.bcp.2010.02.009","article-title":"Mode of action of nifurtimox and N-oxide-containing heterocycles against Trypanosoma cruzi Is oxidative stress involved?","volume":"79","author":"Boiani M","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1017\/S0031182016002602","article-title":"Lysosome-like compartments of Trypanosoma cruzi trypomastigotes may originate directly from epimastigote reservosomes","volume":"144","author":"Vidal JC","year":"2017","journal-title":"Parasitology"}],"container-title":["Mem\u00f3rias do Instituto Oswaldo Cruz"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0074-02762025000101102&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T11:30:28Z","timestamp":1740051028000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0074-02762025000101102&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":33,"alternative-id":["S0074-02762025000101102"],"URL":"https:\/\/doi.org\/10.1590\/0074-02760240183","relation":{},"ISSN":["1678-8060","0074-0276"],"issn-type":[{"value":"1678-8060","type":"electronic"},{"value":"0074-0276","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e240183"}}